Hatchtech board and management changes - PharmaLive.com (press release)
Tuesday, April 21st, 2009|
Hatchtech board and management changes
PharmaLive.com (press release), PA Since joining Hatchtech in 2005, Dr macleman and the board, management and advisors, have moved the company from research to Phase II human trials of the single treatment head lice control product deovo . This is a new generation low-toxicity lousicide … |